Search Results - "Moullet, Isabelle"

Analysis of the StoRM cohort reveals physical activity to be associated with survival in metastatic breast cancer by Delrieu, Lidia, Jacquet, Emmanuelle, Segura-Ferlay, Céline, Blanc, Ellen, Febvey-Combes, Olivia, Friedenreich, Christine, Romieu, Gilles, Jacot, William, Rios, Maria, Heudel, Pierre-Etienne, Roemer-Becuwe, Célia, Jouannaud, Christelle, Tredan, Olivier, Chaigneau, Loïc, Arnedos, Monica, Orfeuvre, Hubert, Quenel-Tueux, Nathalie, Jacquin, Jean-Philippe, Ferrero, Jean-Marc, Moullet, Isabelle, Abadie-Lacourtoisie, Sophie, Penault-Llorca, Frédérique, Cox, David, Bachelot, Thomas

“…Benefits of physical activity are widely demonstrated for early stage cancers but few studies have focused on metastatic disease. The purpose of this study was…”
Get full text

First-line bevacizumab and eribulin combination therapy for HER2-negative metastatic breast cancer: Efficacy and safety in the GINECO phase II ESMERALDA study by Hardy-Bessard, Anne-Claire, Brocard, Fabien, Clatot, Florian, Lortholary, Alain, You, Benoît, Grenier, Julien, Martin-Babau, Jérôme, Lucas, Brigitte, Meunier, Jérôme, Ferrero, Jean-Marc, Savoye, Aude-Marie, Marti, Adina, Despax, Raymond, Moullet, Isabelle, Emile, George

“…Combining bevacizumab with paclitaxel significantly improves progression-free survival (PFS) versus paclitaxel alone in HER2-negative metastatic breast cancer…”
Get full text

Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed by Thieblemont, Catherine, Berger, Françoise, Dumontet, Charles, Moullet, Isabelle, Bouafia, Fadhela, Felman, Pascale, Salles, Gilles, Coiffier, Bertrand

“…Mucosa-associated lymphoid tissue–derived lymphoma (MALT lymphoma) is usually a very indolent lymphoma, described as localized at diagnosis and remaining…”
Get full text

High CD34+ Cell Counts Decrease Hematologic Toxicity of Autologous Peripheral Blood Progenitor Cell Transplantation by Ketterer, Nicolas, Salles, Gilles, Raba, Michel, Espinouse, Daniel, Sonet, Anne, Tremisi, Pierre, Dumontet, Charles, Moullet, Isabelle, Eljaafari-Corbin, Assia, Neidhardt-Berard, Eve-Marie, Bouafia, Fadhela, Coiffier, Bertrand

“…Optimal numbers of CD34+ cells to be reinfused in patients undergoing peripheral blood progenitor cell (PBPC) transplantation after high-dose chemotherapy are…”
Get full text

Factors That Predict Chemotherapy-Induced Myelosuppression in Lymphoma Patients: Role of the Tumor Necrosis Factor Ligand-Receptor System by VOOG, E, BIENVENU, J, WARZOCHA, K, MOULLET, I, DUMONTET, C, THIEBLEMONT, C, MONNERET, G, GUTOWSKI, M.-C, COIFFIER, B, SALLES, G

“…To analyze factors that predict the occurrence of chemotherapy-induced myelosuppression and, in particular, the role of the tumor necrosis factor (TNF)…”
Get full text

Infections following peripheral blood progenitor cell transplantation for lymphoproliferative malignancies: etiology and potential risk factors by Ketterer, N, Espinouse, D, Chomarat, M, Dumontet, C, Moullet, I, Rieux, C, Neidhardt-Berard, E M, Bouafia, F, Coiffier, B, Salles, G

“…We sought to describe the infections that occur after large-dose chemotherapy, which was followed by autologous peripheral blood progenitor cell…”
Get more information

Randomized Phase II Trial Evaluating Two Sequential Treatments in First Line of Metastatic Pancreatic Cancer: Results of the PANOPTIMOX-PRODIGE 35 Trial by Dahan, Laetitia, Williet, Nicolas, Le Malicot, Karine, Phelip, Jean-Marc, Desrame, Jérôme, Bouché, Olivier, Petorin, Caroline, Malka, David, Rebischung, Christine, Aparicio, Thomas, Lecaille, Cédric, Rinaldi, Yves, Turpin, Anthony, Bignon, Anne-Laure, Bachet, Jean-Baptiste, Seitz, Jean-François, Lepage, Come, François, Eric

“…Metastatic pancreatic cancer (mPC) still harbors a dismal prognosis. Our previous trial (PRODIGE 4-ACCORD 11) demonstrated the superiority of 6-month…”
Get full text

Clinico-biological factors predicting the benefit of the LV5FU2 maintenance strategy as a first-line therapy in patients with metastatic pancreatic cancer by Boisteau, Emeric, Dahan, Laetitia, Williet, Nicolas, Le Malicot, Karine, Desramé, Jérôme, Bouché, Olivier, Petorin, Caroline, Malka, David, Rebischung, Christine, Aparicio, Thomas, Lecaille, Cédric, Rinaldi, Yves, Turpin, Anthony, Bignon, Anne-Laure, Bachet, Jean-Baptiste, Lepage, Côme, Granger, Victoire, Legoux, Jean-Louis, Deplanque, Gaël, Baconnier, Mathieu, Lecomte, Thierry, Bonnet, Isabelle, Seitz, Jean-François, François, Eric, Lièvre, Astrid

“…Predictive markers of LV5FU2 maintenance benefit after first-line induction with FOLFIRINOX in patients with metastatic pancreatic cancer are necessary to…”
Get full text

Prognostic impact of ESR1 mutations in ER+ HER2- MBC patients prior treated with first line AI and palbociclib: An exploratory analysis of the PADA-1 trial by Bidard, Francois Clement, Callens, Celine, Dalenc, Florence, Pistilli, Barbara, De La Motte Rouge, Thibault, Clatot, Florian, D'hondt, Veronique, Teixeira, Luis, Vegas, Helene, Everhard, Sibille, Lemonnier, Jerome, Bieche, Ivan, Pradines, Anne, Paitel, Jean FranCois, Spaeth, Dominique, Moullet, Isabelle, Pierga, Jean-Yves, Berger, Frederique, Hardy-Bessard, Anne-Claire, Bachelot, Thomas

“…Abstract only 1010 Background: The question of which is the best endocrine partner to CDK4/6 inhibitors in first line for ER+ HER2- metastatic breast cancer…”
Get full text

Abstract P5-11-22: Clinical and biological efficacy of first line AI and palbociclib in ER+ HER2- MBC with detectable circulating ESR1 mutation prior to treatment initiation by Bidard, François-Clément, Callens, Céline, Dalenc, Florence, Pistilli, Barbara, de la Motte Rouge, Thibault, Clatot, Florian, D'Hondt, Véronique, Teixeira, Luis, Everhard, Sibille, Vegas, Hélène, Lemonnier, Jérôme, Bieche, Ivan, Pradines, Anne, Paitel, Jean-François, Spaeth, Dominique, Canon, Jean-Luc, Moullet, Isabelle, Pierga, Jean-Yves, Berger, Frédérique, Bachelot, Thomas, Delaloge, Suzette

“…Abstract Background: In ER+ HER2- metastatic breast cancer (MBC), activating ESR1 mutations (ESR1mut) confer resistance to aromatase inhibitors (AI) when used…”
Get full text

Relapsed or refractory chronic lymphocytic leukemia retreated with rituximab in daily practice: final results of the PERLE study by Chaoui, Driss, Hacini, Maya, Fitoussi, Olivier, Karlin, Lionel, Arkam, Yazid, Jourdan, Eric, Orfeuvre, Hubert, Voillat, Laurent, Sanhes, Laurence, Leprêtre, Stéphane, Liu, Kun Lun, Barry, Marly, Tempescul, Adrian, Dilhuydy, Marie-Sarah, Chaib, Abdelaziz, Slama, Borhane, Labourey, Jean Luc, Benbrahim, Omar, Dreyfus, Brigitte, Mahé, Béatrice, Maynadié, Marc, Delmer, Alain, Benkanoun, Chahinez, Boissard, Frédéric, Gandon, Sophie, Veerabudun, Kalaivani, Choquet, Sylvain

Get full text

Arobase: A phase III trial of exemestane (Exe) and bevacizumab (BEV) as maintenance therapy in patients (pts) with metastatic breast cancer (MBC) treated in first line with paclitaxel (P) and BEV—A Gineco study by Tredan, Olivier, Follana, Philippe, Moullet, Isabelle, Cropet, Claire, Trager-Maury, Stéphanie, Dauba, Jérôme, Lavau-Denes, Sandrine, Dieras, Veronique, Beal-Ardisson, Dominique, Gouttebel, Marie-Claude, Orfeuvre, Hubert, Pujade-Lauraine, Eric, Bachelot, Thomas Denis

“…Abstract only…”
Get full text

Photodynamic therapy for choroidal metastasis from lung adenocarcinoma by Mauget‐Faÿsse, Martine, Gambrelle, Joël, Quaranta‐El Maftouhi, Maddalena, Moullet, Isabelle

“…xxx…”
Get full text

Factors associated with successful mobilization of peripheral blood progenitor cells in 200 patients with lymphoid malignancies by Ketterer, Nicolas, Salles, Gilles, Moullet, Isabelle, Dumontet, Charles, Eljaafari‐Corbin, Assia, Tremisi, Pierre, Thieblemont, Catherine, Durand, Brigitte, Neidhardt‐Berard, Eve‐Marie, Samaha, Hanadi, Rigal, Dominique, Coiffier, Bertrand

“…Peripheral blood progenitor cells (PBPC) were mobilized and harvested in 200 patients treated for non‐Hodgkin's lymphoma (n = 148), Hodgkin's disease (n = 22)…”
Get full text

Comparison of chemotherapy to radiotherapy as consolidation of complete or good partial response after six cycles of chemotherapy for patients with advanced Hodgkin’s disease: results of the Groupe d’études des Lymphomes de l’Adulte H89 trial by Fermé, Christophe, Sebban, Catherine, Hennequin, Christophe, Diviné, Marine, Lederlin, Pierre, Gabarre, Jean, Ferrant, Augustin, Caillot, Denis, Bordessoule, Dominique, Brice, Pauline, Moullet, Isabelle, Berger, Françoise, Lepage, Eric

“…The treatment of advanced Hodgkin's disease (HD) with chemotherapy (CTx) alone or combined modality treatments has been controversial. In 1989, we designed a…”
Get full text

Ab-initio molecular dynamics study of the interaction of aluminium clusters on a graphite surface by Moullet, Isabelle

“…We have used the Car-Parrinello method to study the interaction of aluminium clusters containing up to 13 atoms with a graphite substrate. For all clusters, we…”
Get full text

Bevacizumab plus microtubule targeting agents in heavily pre-treated ovarian cancer patients: a retrospective study by Asmane, Irène, Kurtz, Jean-Emmanuel, Bajard, Agathe, Guastalla, Jean-Paul, Meeus, Pierre, Tredan, Olivier, Labidi Galy, Intidhar, Moullet, Isabelle, Ardisson, Philippe, Vincent, Lionel, Coeffic, David, Dufresne, Armelle, Bergerat, Jean-Pierre, Ray-Coquard, Isabelle

“…As vascular endothelial growth factor (VEGF) is expressed in ovarian cancer, we assessed the efficacy and safety of bevacizumab (a monoclonal antibody…”
Get full text

Epoetin Beta once-weekly therapy in anemic patients with solid tumors and non-myeloid hematological malignancies receiving chemotherapy by Spaëth, Dominique, Desablens, Bernard, Rodon, Philippe, Mennecier, Bertrand, Oudard, Stéphane, Moullet, Isabelle, Ghomari, Kamel, Bergougnoux, Loïc, Bleuzen, Pascal, Jenabian, Arash, Ifrah, Norbert

“…This study aimed to provide further clinical evidence for the efficacy and safety of epoetin beta once weekly across a wide range of cancer types. This was a…”
Get more information

High CD34+ cell counts decrease hematologic toxicity of autologous peripheral blood progenitor cell transplantation by KETTERER, N, SALLES, G, BOUAFIA, F, COIFFIER, B, RABA, M, ESPINOUSE, D, SONET, A, TREMISI, P, DUMONTET, C, MOULLET, I, ELJAAFARI-CORBIN, A, NEIDHARDT-BERARD, E.-M

“…Optimal numbers of CD34(+) cells to be reinfused in patients undergoing peripheral blood progenitor cell (PBPC) transplantation after high-dose chemotherapy…”
Get full text

Si(111):Na: structural and electronic properties from ab initio molecular dynamics by MOULLET, I, ANDREONI, W, PARRINELLO, M

Get full text